LI Xun,HE Canming,WANG Luwen,et al.. Hepatic expression of histone deacetylase 2 in rats with acute liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(5): 325-327.
[1] ANNEMIEKE J,DE RUIJTER M,ALBERT H,et al. Histone deacetylases(HDACs): characterization of the classical HDAC family[J]. Biochem J,2003,370(3):737-749. [2] OLIVER HK. HDAC2: a critical factor in health and disease[J]. Trends Pharmacol Sci,2009,30(12):647-655. [3] PETER J. Histone deacetylase-2 and airway disease[J]. Ther Adv Respir Dis,2009,3(5):235-243. [4] 何灿明,王鲁文,任巧晶,等. 丙酮酸乙酯对D-氨基半乳糖诱导的急性肝损伤大鼠的保护作用[J]. 实用肝脏病杂志,2009,12(5):329-388. [5] ITO K,CARAMORI G. Expression and activity of histone deacetylases in human asthmatic airways[J]. Am J Respir Crit Care Med,2002,166(3):392-396. [6] 胡玉川,徐峰. Kupffer细胞在内毒素诱导肝损伤发病机制中的作用[J]. 世界华人消化杂志,2008,16(24):2751-2755. [7] 林海,李泽信. 核因子-кB与肝损伤[J]. 中国普外基础与临床杂志,2007,14(6):731-734. [8] CHEN E,SHI X. NF-kappa B,a pivotal transcription factor in silica-induced diseases[J]. Mol Cell Biochem,2002,234-235(1-2):169-176. [9] BRIAN P,WESTERNHEIDE SD. The p65(RelA) subunit of NF-кB interacts with the histone deacetylase (HDAC)corepressors HDAC1 and HDAC2 to negatively regulate gene expression[J]. Mol Cell Biol,2001,21(20):7065-7077. [10] DAS UN. Is pyruvate an endogenous anti-inflammatory molecule[J]. Nutrition,2006,22(9):965-972. [11] JOHNSTONE RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer[J]. Nat Rev Drug Discov,2002,1(4):287-299.